Tag: Human Papillomavirus (HPV)
Public Awareness Low About HPV, HPV Vaccination, HPV-Linked Cancer
34.3 and 37.6 percent of U.S. adults were reportedly unaware of HPV and lacked awareness about the HPV vaccine, respectively
Updated Guidance Improves Staging of HPV-Positive Oropharyngeal Cancer
AJCC9V staging system showed superior hazard consistency, outcome prediction, and balance, but not hazard discrimination
Parents Appear Receptive to Children Receiving HPV Vaccine at 9 or 10 Years of...
Most pushback due to child expectations of vaccine-free visit at 9 years; discussions shorter since sexual activity not perceived as salient
HPV Genome Sequencing Superior in Detecting Head & Neck Cancer
Whole-genome sequencing-based ctHPVDNA detection has highest sensitivity, specificity for HNSCC
Survey Reveals Common Misconceptions About Human Papillomavirus
Majority of respondents unaware HPV is more common in men than women
Therapeutic Vaccine Shows Preliminary Safety, Effectiveness for HPV16+ Cervical Precancerous Condition
50 percent of patients with CIN3 had histopathological complete response; 63 percent had HPV16 clearance
Many Lack Knowledge of Link Between HPV and Oropharyngeal Cancer
No change seen in knowledge of the association from 2018 to 2020 among adults, focusing on those aged 27 to 45 years
Vaccination of 27- to 45-Year-Olds Against HPV Is Less Cost-Effective
Vaccination of 'mid-adults,' including those at higher risk, results in higher number needed to vaccinate than that seen for younger people
Women Want a Choice Between Vaginal HPV Self-Sampling and Clinician Screen
However, some feel it would be difficult to choose
One-Dose HPV Vaccination Averts Similar Number of Cancers as Two Doses
Under most pessimistic scenario, one dose would avert fewer cervical cancer cases with difference of 3 percent over 100 years
